당뇨망막병증 시장 : 질환 유형별, 치료 유형별, 투여 경로별, 최종 용도별, 유통 채널별, 지역별
Diabetic Retinopathy Market, By Disease Type, By Treatment Type, By Route of Administration, By End User, By Distribution Channel, By Geography
상품코드
:
1672637
리서치사
:
Coherent Market Insights
발행일
:
2025년 02월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 당뇨망막병증 시장은 2025년에 99억 1,000만 달러로 추정되며, 2032년에는 154억 달러에 달할 것으로 예측되며, 2025-2032년에 CAGR 6.5%로 성장할 전망입니다.
| 보고 범위 |
보고서 상세 내용 |
| 기준연도 |
2024년 |
2025년 시장 규모 |
99억 1,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간: 2025-2032년 CAGR: |
6.50% |
2032년 가치 예측 |
154억 달러 |
도표. 2025년 지역별 당뇨병성 망막증 시장 점유율(%)
당뇨망막병증은 당뇨병의 합병증으로 망막에 장애가 발생하는 질환입니다. 당뇨병에 따른 고혈당 수치는 망막 내부의 혈관을 손상시킬 수 있습니다. 당뇨병성 망막증은 1형 당뇨병과 2형 당뇨병 모두에서 발생하며, 현역 세대의 실명의 주요 원인이 되고 있습니다. 세계 당뇨망막병증 시장은 당뇨병 유병률 증가, 당뇨망막병증 진단 및 치료에 대한 인식 증가, 첨단 망막 스크리닝 기술의 가용성에 힘입어 성장세를 보이고 있습니다. 그러나 고가의 치료 비용과 불충분한 상환 정책은 시장 성장을 제한하고 있습니다.
시장 역학:
망막 검진, 약물, 수술의 높은 비용, 신흥 국가의 안과 의사 부족, 일부 국가의 불충분한 보험 적용이 시장 성장을 저해할 것으로 예상됩니다. 주요 기회는 당뇨병성 망막증을 보다 빠르고 정확하게 감지할 수 있는 비용 효율적인 스크리닝 솔루션, 병용 치료제, 인공지능 기반 분석 플랫폼의 개발에 있습니다.
본 조사의 주요 특징
세계의 당뇨병성 망막증 시장을 상세하게 분석하여 예측 기간(2025-2032년, 2024년을 기준 연도) 시장 규모와 연평균 성장률(CAGR%)을 게재하고 있습니다.
또한 다양한 부문에 걸친 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 당뇨병성 망막증 시장의 주요 기업 개요을 제공합니다.
본 조사의 대상이 되는 주요 기업에는 Novartis AG, Bayer AG, Regeneron Pharmaceuticals Inc., Roche Holding AG, Allergan PLC, Zeiss International, Topcon Corporation, Heidelberg Engineering GmbH, Optos PLC, Canon Inc., Nidek Co.Ltd., Ellex Medical Lasers Limited, Bausch+Lomb Incorporated, Abbott Laboratories, Santen Pharmaceutical Co., Ltd. 등이 있습니다.
이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
세계 당뇨병성 망막증 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장의 전망
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER의 산업 분석
- 합병과 인수 시나리오
- 업계 동향
제4장 세계의 당뇨망막병증 시장, 질환 유형별, 2020-2032년, (10억 달러)
제5장 세계의 당뇨망막병증 시장, 치료 유형별, 2020-2032년, (10억 달러)
- 항혈관 내피 성장인자 요법
- 안내 스테로이드 주사
- 레이저 수술
- 초자체 절제술
- 기타(안내 스테로이드약 등)
제6장 세계의 당뇨망막병증 시장, 투여 경로별, 2020-2032년, (10억 달러)
- 초자체내 주사
- 초자체내 임플란트
- 경구
- 국소용 점안약
- 레이저 수술
- 기타
제7장 세계의 당뇨망막병증 시장, 최종 용도별, 2020-2032년, (10억 달러)
- 병원
- 안과 클리닉
- 외래 수술 센터
- 장기 케어 센터
- 기타
제8장 세계의 당뇨망막병증 시장, 유통 채널별, 2020-2032년(10억 달러)
제9장 세계의 당뇨망막병증 시장, 지역별, 2020-2032년, 가치(10억 달러)
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제10장 경쟁 구도
- Novartis AG
- Bayer AG
- Regeneron Pharmaceuticals Inc.
- Roche Holding AG
- Allergan PLC
- Zeiss International
- Topcon Corporation
- Heidelberg Engineering GmbH
- Optos PLC
- Canon Inc.
- Nidek Co., Ltd.
- Ellex Medical Lasers Limited
- Bausch+Lomb Incorporated
- Abbott Laboratories
- Santen Pharmaceutical Co., Ltd.
제11장 애널리스트의 권장사항
- 운명의 수레바퀴
- 애널리스트의 견해
- COM(Coherent Opportunity Map)
제12장 참고 문헌과 조사 방법
KSA
영문 목차
Global Diabetic Retinopathy Market is estimated to be valued at USD 9.91 Bn in 2025 and is expected to reach USD 15.40 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 9.91 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
6.50% |
2032 Value Projection: |
USD 15.40 Bn |
Figure. Diabetic Retinopathy Market Share (%), By Region 2025
Diabetic retinopathy is a medical condition in which damage occurs to the retina due to complications of diabetes mellitus. High blood sugar levels associated with diabetes can damage blood vessels inside the retina. Diabetic retinopathy occurs in both type 1 and type 2 diabetes and is a leading cause of blindness among working-age adults. The global diabetic retinopathy market is driven by rising prevalence of diabetes, increasing awareness regarding diabetic retinopathy diagnosis and treatment, and the availability of advanced retinal screening techniques. However, high cost of treatment and inadequate reimbursement policies limit the market growth.
Market Dynamics:
High cost of retinal screening, drugs, and surgeries, shortage of ophthalmologists in developing nations, and inadequate insurance coverage in some countries are expected to restrain the market growth. Key opportunity lies in development of cost-effective screening solutions, combinational therapeutics, and artificial intelligence-powered analytic platforms to detect diabetic retinopathy faster and more accurately.
Key Features of the Study:
This report provides in-depth analysis of the global diabetic retinopathy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diabetic retinopathy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, Bayer AG, Regeneron Pharmaceuticals Inc., Roche Holding AG, Allergan PLC, Zeiss International, Topcon Corporation, Heidelberg Engineering GmbH, Optos PLC, Canon Inc., Nidek Co., Ltd., Ellex Medical Lasers Limited, Bausch + Lomb Incorporated, Abbott Laboratories, and Santen Pharmaceutical Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global diabetic retinopathy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
- By Disease Type Insights (Revenue, USD Bn, 2019 - 2032)
- Proliferative Diabetic Retinopathy
- Non-proliferative Diabetic Retinopathy
- By Treatment Type Insights (Revenue, USD Bn, 2019 - 2032)
- Anti-Vascular Endothelial Growth Factor Therapy
- Intraocular Steroid Injection
- Laser Surgery
- Vitrectomy
- Others (Intraocular Corticosteroids, etc.)
- By Route of Administration Insights (Revenue, USD Bn, 2019 - 2032)
- Intravitreal Injections
- Intravitreal Implants
- Oral
- Topical Eye Drops
- Laser Surgery
- Others
- By End User Insights (Revenue, USD Bn, 2019 - 2032)
- Hospitals
- Ophthalmology Clinics
- Ambulatory Surgery Centers
- Long-Term Care Centers
- Others
- By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Regional Insights (Revenue, USD Bn, 2019 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Novartis AG
- Bayer AG
- Regeneron Pharmaceuticals Inc.
- Roche Holding AG
- Allergan PLC
- Zeiss International
- Topcon Corporation
- Heidelberg Engineering GmbH
- Optos PLC
- Canon Inc.
- Nidek Co., Ltd.
- Ellex Medical Lasers Limited
- Bausch + Lomb Incorporated
- Abbott Laboratories
- Santen Pharmaceutical Co., Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Diabetic Retinopathy Market, By Disease Type
- Global Diabetic Retinopathy Market, By Treatment Type
- Global Diabetic Retinopathy Market, By Route of Administration
- Global Diabetic Retinopathy Market, By End User
- Global Diabetic Retinopathy Market, By Distribution Channel
- Global Diabetic Retinopathy Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Diabetic Retinopathy Market, By Disease Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Proliferative Diabetic Retinopathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Non-proliferative Diabetic Retinopathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Diabetic Retinopathy Market, By Treatment Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Anti-Vascular Endothelial Growth Factor Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intraocular Steroid Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Laser Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Vitrectomy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Intraocular Corticosteroids, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Diabetic Retinopathy Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Intravitreal Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intravitreal Implants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Topical Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Laser Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Diabetic Retinopathy Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ophthalmology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Long-Term Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Diabetic Retinopathy Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Diabetic Retinopathy Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Disease Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Regeneron Pharmaceuticals Inc.
- Roche Holding AG
- Allergan PLC
- Zeiss International
- Topcon Corporation
- Heidelberg Engineering GmbH
- Optos PLC
- Canon Inc.
- Nidek Co., Ltd.
- Ellex Medical Lasers Limited
- Bausch + Lomb Incorporated
- Abbott Laboratories
- Santen Pharmaceutical Co., Ltd.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
관련자료
